Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 3
2002 1
2003 3
2004 2
2005 1
2006 5
2007 8
2008 3
2009 7
2010 6
2011 5
2012 7
2013 8
2014 7
2015 6
2016 2
2017 2
2018 3
2019 2
2020 2
2021 3
2022 2
2023 3
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Feagan BG, et al. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734. N Engl J Med. 2013. PMID: 23964932 Free article. Clinical Trial.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. Duerr RH, et al. Among authors: dassopoulos t. Science. 2006 Dec 1;314(5804):1461-3. doi: 10.1126/science.1135245. Epub 2006 Oct 26. Science. 2006. PMID: 17068223 Free PMC article.
Ulcerative Colitis Care Pathway.
Dassopoulos T, Cohen RD, Scherl EJ, Schwartz RM, Kosinski L, Regueiro MD. Dassopoulos T, et al. Gastroenterology. 2015 Jul;149(1):238-45. doi: 10.1053/j.gastro.2015.05.036. Epub 2015 May 27. Gastroenterology. 2015. PMID: 26025078 Review. No abstract available.
Maneuvering Clinical Pathways for Ulcerative Colitis.
Johnson CM, Linzay CD, Dassopoulos T. Johnson CM, et al. Among authors: dassopoulos t. Curr Gastroenterol Rep. 2019 Sep 5;21(10):52. doi: 10.1007/s11894-019-0716-3. Curr Gastroenterol Rep. 2019. PMID: 31486929 Review.
Thiopurine therapy in inflammatory bowel disease.
Ha C, Dassopoulos T. Ha C, et al. Among authors: dassopoulos t. Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59. Expert Rev Gastroenterol Hepatol. 2010. PMID: 20932143 Review.
88 results